Remove 2025 Remove Communication Remove Insurance
article thumbnail

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

Drug Topics: What will be the likely impacts of this change that pharmacists will need to communicate with their patients? This schedule also helped dictate insurance coverage of those recommended vaccines.

Vaccines 520
article thumbnail

Q&A: Expert Highlights Importance of Trusted Sources for Vaccine Information

Drug Topics

She warned that changes in vaccine recommendations could impact insurance coverage, patient access, and ultimately public health, particularly for vulnerable populations like low-income children.

Vaccines 341
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Changing the PAP Model

Pharmaceutical Commerce

As benefits and patient eligibility to federal and state insurance programs continue to evolve, PAP programs are poised to take on even greater importance for vulnerable people seeking access to critical prescription medications in the US.

article thumbnail

Bharat Biotech acquires licence for GSK’s Shigella vaccine development

Pharmaceutical Technology

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

article thumbnail

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

GlobalData Healthcare June 19, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The oligonucleotide market is well-positioned to drive the next wave of personalised treatment. billion from 2021 to 2025 year-to-date. Credit: Kateryna Kon via Shutterstock. ASOs accounted for more than half ($3.54

article thumbnail

European pharma needs scalable models to succeed in US

Pharmaceutical Technology

Abigail Beaney June 17, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook With potential tariffs and other changes in the US market, it is important for European companies to show they have a scalable model if they want to break into the market. Give your business an edge with our leading industry insights.

article thumbnail

Novartis concludes Regulus Therapeutics acquisition

Pharmaceutical Technology

June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regulus becomes Novartis’ indirect wholly owned subsidiary. Find out more The development follows an agreement in April 2025 in which Novartis signed an agreement to acquire Regulus and its oligonucleotide therapy, farabursen. Credit: JHVEPhoto/Shutterstock.